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INTRODUCTION
Synthetic bone substitutes are very promising in bone 
regeneration because their availability is unlimited; they 
can be tailored as a patient-specific implant via computer-
aided design. Furthermore, antigenicity or infection trans-
mission is excluded.1 Nevertheless, no material currently 
available fulfills the ideal criteria for cranial reconstruction. 
The newly formed bone should fully replace an implant, 
while the mechanical properties of the grafted area meets 
functional demands and the shape remains unchanged.2 
Since many years, metallic (titanium alloy), polymeric 
[polymethylmethacrylate (PMMA) and more recently 
polyetheretherketone], ceramic (calcium phosphates3), 
and bioactive glasses4 are available for clinical use.5 Metal-
lic implants interfere magnetic resonance images6; more-
over, exposition and infection are possible complications.3 
PMMA materials are predisposed to exposure because of 
infection, especially in large implants in irradiated tissue 
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Background: The aim of the study was to evaluate the integrity of a craniotomy graft-
ed site in a minipig model using different highly porous calcium phosphate ceramic 
scaffolds either loaded or nonloaded with bone morphogenetic protein-7 (BMP-7).
Methods: Four craniotomies with a diameter of 15 mm (critical-size defect) were 
grafted with different highly porous (92–94 vol%) calcium phosphate ceramics 
[hydroxyapatite (HA), tricalcium phosphate (TCP), and biphasic calcium phos-
phate (BCP; a mixture of HA and TCP)] in 10 Göttingen minipigs: (a) group I 
(n = 5): HA versus BCP; (b) group II (n = 5): TCP versus BCP. One scaffold of each 
composition was supplied with 250 μg of BMP-7. In vivo computed tomography 
scan and fluorochrome bone labeling were performed. Specimens were evaluated 
14 weeks after surgery by environmental scanning electron microscopy, fluores-
cence microscopy, and Giemsa staining histology.
Results: BMP-7 significantly enhanced bone formation in TCP (P = 0.047). Slightly 
enhanced bone formation was observed in BCP (P = 0.059) but not in HA implants. 
BMP-7 enhanced ceramic degradation in TCP (P = 0.05) and BCP (P = 0.05) im-
plants but not in HA implants. Surface integrity of grafted site was observed in all 
BMP-7-loaded implants after successful creeping substitution by the newly formed 
bone. In 9 of 10 HA implants without BMP-7, partial collapse of the implant site 
was observed. All TCP implants without BMP-7 collapsed. Fluorescent labeling 
showed bone formation at week 1 in BMP-7-stimulated implants.
Conclusions: BMP-7 supports bone formation, ceramic degradation, implant in-
tegration, and surface integrity of the grafted site. (Plast Reconstr Surg Glob Open 
2017;5:e1255; doi: 10.1097/GOX.0000000000001255; Published online 16 March 2017.)
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and in proximity to the sinuses in frontal cranioplasty.3,7 
Hydroxyapatite (HA) implants showed a limited osteoin-
tegration and limited resorption in the craniomaxillofa-
cial area.8 Despite the above-mentioned disadvantages, all 
these materials are routinely used in adults.3 Moreover, 
custom-made nonresorbable implants are not suitable for 
children because cranial expansion cannot be restrained. 
Cranial bone defects in the growing infant are relatively 
common after cranial vault reshaping in craniosynostosis 
surgery. The autologous bone graft is still the gold standard 
for cranial reconstruction in children. Rib bone trans-
plant is of limited use because this kind of bone resorbs, 
producing a “washboard” appearance, which is not accept-
able in aesthetic regions like the forehead.3 Cranial bone 
transplant seems to be more stable because cranial bone 
is more resistant to resorption.9 Techniques on harvesting 
cranial bone grafts mark the foundation of craniofacial 
surgery. Tessier et al.10 reported more than 20,000 cases in 
which a bone defect of the craniofacial and maxillofacial 
area was treated by a bone graft. Detailed information on 
techniques and tools for harvesting full-thickness cranial 
bone grafts and split cranial bone grafts for transposition 
and also particulate cranial bone graft for small defects 
was provided.11 Despite the benefit of the autologous bone 
graft, the major limitation is the limited source. Bone mor-
phogenetic proteins (BMPs) in an osteoconductive carrier 
showed to be valuable in craniomaxillofacial surgery.2,12 
Springer et al.13 reported about cranial reconstruction in 
the growing Göttinger minipig using a collagen scaffold 
loaded with BMP-7. An unrestricted skull growth was ob-
served. Nevertheless, for the repair of big cranial defects, 
a collagen carrier for BMP is not suitable because an ana-
tomical implant design is not possible. Biphasic calcium 
phosphate (BCP) ceramics [a mixture of HA and tricalci-
um phosphate (TCP)] seem to be promising materials as 
cranial implant because the addition of TCP to HA allows 
remodeling via degradation.8 Furthermore, computer-aid-
ed design technology is applicable to calcium phosphate 
ceramics (CPCs). The replacement of a ceramic scaffold 
by the newly formed bone is a critical issue, especially in 
craniofacial surgery, because implant geometry should 
remain unaltered until bone replacement takes over to 
meet the highly aesthetic demands of this area. The calci-
um phosphate composition, sintering, and pore geometry 
play a critical role in bone regeneration and remodeling 
as observed in the present ceramic in in vitro studies14,15 
and in vivo in the ectopic mouse model.16 CPCs are suit-
able carriers for BMPs as demonstrated by Urist et al.17 and 
Ripamonti et al.18 among other authors.
The aim of the present study was to evaluate the effect 
of BMP-7 on different CPCs in a Göttinger minipig crani-
otomy model in terms of integrity of the implant site after 
ceramic creeping substitution by the newly formed bone.
MATERIALS AND METHODS
Ten adult Göttingen minipigs aged in average 36 
months and weighing in average 33–41 kg (Ellengard Göt-
tingen Minipigs ApS, Dalmose, Denmark) were operated 
on. The animals were fed with 2 × 250 g standard soft diet 
(Altromin 9023; Atronium International GmbH, Lange, 
Germany) and water ad libitum. The present study was ap-
proved by the local authorities for animal protection at 
Oberpfalz, Bavaria (No. 54-2531.1-02/07) and the Ethics 
Committee at the University of Regensburg, Germany. All 
experiments were performed at the Experimental Animal 
Facility at the University of Regensburg.
Experimental Procedure
The frontal bone was shaved and cleaned with povi-
done iodine solution and draped with sterile towels in a 
prone position. Five craniotomy critical-size defects with 
a diameter of 15 mm (Craniotome Type GA054/74; Aes-
culap, Tuttlingen, Germany) were set in the frontal bone, 
preserving the sinus mucosa at a distance of 2.5 cm from 
the midline and 2.5 cm from each other at the ipsilateral 
site (Fig. 1). Due to the maturity of the animals, the whole 
frontal bone was pneumatized by frontal sinus; no dura 
mater was exposed. Four bone defects were grafted with 
different highly porous CPCs [HA, TCP, and BCP (HA/
TCP in a ratio of 60/40 wt% = HA60)] developed at the 
Friedrich-Baur-Research-Institute for Biomaterials, Uni-
versity of Bayreuth, Germany, not clinically available yet. 
The fifth defect remained ungrafted as a control defect 
(Fig. 1). The CPCs used had interconnecting macropores 
with a bimodal pore size distribution (360–440 and 900–
1150 mm). The surface of the ceramic struts was micropo-
rous with pores of the size 0.4–4 μm. The total porosity of 
the CPCs was very high (92–94 vol%) as reported previ-
ously.14,16,19 One scaffold of each composition was supplied 
with 250 μg of BMP-7 diluted in 20 mM acetate buffer with 
5% mannitol (pH = 4.5), providing full embedment of the 
implant (generous gift from Prof. S. Vukicevic, Laboratory 
for Mineralized Tissues Center for Translational and Clini-
cal Research, University of Zagreb, School of Medicine and 
Genera, Krapinske Toplice, Croatia). BMP-7 was supplied 
in situ by using a pipette (Pipette; Eppendorf Research 
Fig. 1. medial subperiosteal scalp dissection showing 5 craniotomies 
with a diameter of 15 mm. two defects are localized anteriorly at 
1 cm above the supraorbital foramen and a distance of 2.5 cm from 
the midline (below; frontal). two more defects are placed posteriorly 
at 15 mm from the anterior defects (above; occipital). a lateral de-
fect (left side in reference to the specimens) remained ungrafted as 
a control site. Craniotomies are grafted with different CpCs (Ha, tCp, 
and BCp) loaded alternatively with 250 μg of Bmp-7 applied in situ.
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plus, Hamburg, Germany) with sterile tips. Ripamonti20 
informed about the same effect on bone formation by ap-
plying 0.1, 0.5, or 2.5 mg of BMP-7 in a craniotomy model 
in the adult baboons, Papio ursinus. Consequently, the ap-
plied doses in the present study should be appropriate. 
BMP-7 was selected to compare results with the authors’ 
previous studies using the same ceramic.14,16 Groups work-
ing on BMP-2 inform about similar results in terms of 
bone formation.21
Two animal groups were set up (each n = 5): group I: 
HA and BCP with and without BMP-7 (4 implants in each 
animal); group II: TCP and BCP with or without BMP-7 
(4 implants in each animal; Fig. 2). In total, 40 implants 
were evaluated and compared for statistical purposes: HA 
(n = 5), TCP (n = 5), BCP (n = 10), HA + BMP-7 (n = 10), 
TCP + BMP-7 (n = 5), and BCP + BMP-7 (n = 10).
In vivo computed tomography (CT) was performed 
at weeks 1, 10, and 14 after surgery in intravenous anes-
thesia. CT was performed with a 16-slice spiral CT scan-
ner (Siemens Somatom Plus 4/Sensation 16; Siemens, 
Erlangen, Germany) with the following scan parameters: 
120 kV, 33 mA, and slice thickness of 1 mm. Images were 
analyzed on a Syngo 3D Workstation Leonardo (Siemens, 
Erlangen, Germany).
The parameters evaluated according to Parfitt22 were 
as follows:
-  Core volume = bone volume + mineralized surface 
(area in mm2)
-  Implant height = distance mineralized surface from 
implant bed to skull surface (mm)
- Implant density (HU)
An in vivo polychrome sequential labeling of mineralizing 
tissues was performed as described previously.23,24 Sequen-
tial apposition of fluorochromes provides information 
about temporal bone formation in vivo. Intraperitoneal 
injection of fluorochromes started 1 week after the surgi-
cal procedure and continued sequentially in weeks 6, 8, 
and 12 after surgery as follows: xylenol orange (6% in 2% 
NaHCO3 solution, 1.5 ml/kg body weight), calcein green 
(1% in 2% NaHCO3 solution, 5 ml/kg body weight), aliza-
rin complexon (3% in 2% NaHCO3 solution, 0.8 ml/kg 
body weight), and doxycycline (1 ml/kg body weight; Ra-
tiopharm GmbH and Co., Ulm, Germany). Images were 
evaluated with a fluorescent microscope using universal 
objective for simultaneous capture of all fluorochromes 
injected (BX16; Olympus, Düsseldorf, Germany). Im-
ages were analyzed with Cell P (Olympus Soft Imaging 
Solutions GmbH, Muenster, Germany). Selective fluoro-
chrome evaluation and three-dimensional (3D) image 
analysis were performed by using a confocal laser scan-
ning microsocope LSM 510 (Zeiss, Jena, Germany).
Animals were killed 14 weeks after surgery by an 
intravital and intracardial perfusion of a saline and a 
fixation solution [25% glutaraldehyde (2.5%), form-
aldehyde (1.5%), and Sörensen’s phosphate buffer 
(100 mM KH2PO4, 100 mM Na2HPO4 × 2H2O, pH 7.4)] 
at 37°C and a pressure of 120 mm Hg as described pre-
viously12,24; a lateral thoracotomy was preferred. A me-
chanical pump Medos Deltastream DP2 and a Jostra 
Heat Exchanger HEC44 were used (Heart Technology 
Facility, Department of Cardiothoracic Surgery, Univer-
sity of Regensburg).
Fig. 2. Craniotomy model in the Göttingen minipig with 5 critical-size defects placed in the frontal 
bone. Four defects are grafted with different CpCs; the fifth defect in the left frontal bone remained 
empty as control. two animal groups were set up (each n = 5). Group i: Ha vs BCp with and without 
Bmp-7. implants were alternatively placed in the right and in the left side; Group ii: tCp vs BCp with or 
without Bmp-7.
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Histology
Each sample was harvested en block and sectioned in 
the middle after performing an x-ray of the frontal bone. 
The surrounding soft tissues were preserved to avoid al-
teration of the implant surface (cranial implant). Ex-
planted specimens were dehydrated in a graded series of 
alcohol and, subsequently, embedded in methylmethacry-
late (MMA).25 The polished surface of an MMA block was 
analyzed by environmental scanning electron microscopy 
(ESEM; Quanta 200; FEI, Hillsboro, Ore.) at 0.5–0.6 mbar 
and 15 kV and a magnification of ×150 as described pre-
viously.16 The following parameters were evaluated22 by 
using an imaging software analySIS Pro3.2 (Soft Imaging 
Systems GmbH, Muenster, Germany):
- Area of the newly mineralized bone
- Area of the ceramic (ratio evaluated in percentage)
-  Integrity of the implant site is scored as collapse (yes; 
no) defined as follows: Collapse = shrinking of the 
implant site producing irregularity and depression 
of mineralized surface in reference to the skull sur-
face; No collapse = surface integrity of the implant 
site in line with the skull profile as a result of success-
ful creeping substitution of the implant by the newly 
formed bone.
An unimplanted ceramic embedded in MMA (native 
ceramic) was evaluated as control to evaluate ceramic gray 
values as a reference for ceramic degradation (dissolution 
or resorption) in the experimental group. Subsequently, 
the MMA blocks were cut, ground, and polished into sec-
tions with a thickness of 90 μm. Those sections were evalu-
ated for fluorescence labeling12 and then stained with 
Giemsa to evaluate the newly formed bone, bone marrow, 
and integrity of sinus mucosa.16,26
Statistical Analysis
The statistical analysis was done with Stata 10.1 SE 
for Windows (StataCorp, Inc., College Station, Tex.) and 
SigmaPlot 11 for Windows (SYSTST Inc., Chicago, Ill.). 
Graphs were created with SigmaPlot 11. Data were graphi-
cally tested for normality with Q-Q plots, followed by a for-
mal analysis with the Shapiro-Wilk test.
Continuous, normally distributed data from more than 
2 groups were compared with analysis of variance followed 
by pairwise comparison (Holm-Sidak). Comparison of 
2 groups was done by Student’s t test. Comparison of con-
tinuous non-normally distributed data from more than 
2 groups was performed with the Kruskal-Wallis test, fol-
lowed by a pairwise analysis with the Mann-Whitney test.
Data are presented as mean value ± SD. A P value 
< 0.05 was considered as statistically significant.
RESULTS
Animals gained 5% weight during the experimental 
period in average, the surgical procedure was well toler-
ated, and no complications were observed.
CT Data Correlated to Fluorescent Labeling and ESEM 
Imaging
CT data showed an increment in the implant volume 
(core volume) in the presence of BMP-7 (Fig. 3). In the 
absence of BMP-7, TPC ceramics were almost not detect-
able by week 10; a slight bone volume enhancement was 
observed by week 14 (Fig. 3). This observation correlates 
Fig. 3. implant volume assessed in vivo by Ct at weeks 1, 10, and 14. tCp ceramics 
drastically lost volume at week 10; some volume recovered as observed at week 14. 
this is explained by late bone formation, evident in fluorochrome labeling at week 
10 (see also Fig. 7). Bmp-7-loaded ceramics showed a statistically significant volume 
increment for Ha and BCp ceramics (Student’s t test after testing for normality).
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with late bone formation (doxycycline marker = brown, 
week 12) on a collapsed TCP scaffold as observed in the 
fluorescent labeling (Fig. 8). The 3D CT visualization data 
showed a smoother surface on BMP-7-loaded implants 
(Fig. 4); surface irregularities in the 3D reconstruction 
correspond to the immature newly formed bone not de-
tected by CT as confirmed by the ESEM imaging (Fig. 5). 
The control craniotomy remained unhealed, confirming 
the nature of the defect as a critical-size defect (Fig. 4).
Environmental Scanning Electron Microscopy
Analysis of the ESEM images by segmentation of gray 
values is provided in Figure 5. The newly formed bone 
was seen in all implants. BMP-7 enhanced bone forma-
tion in TCP (P = 0.047); a slightly enhanced bone for-
mation was observed in BCP (P = 0.059) but not in HA 
implants (Fig. 6). Despite no enhanced bone formation 
on HA + BMP-7, slight overgrowth of bone in relation 
to the skull profile was observed. The implant site “ex-
panded” because no HA degradation took place (Fig. 5, 
left above). BMP-7 also enhanced ceramic degradation in 
TCP (P = 0.05) and BCP (P = 0.05) implants but again not 
in HA implants (Fig. 7). The integrity of the implant site 
was also influenced by BMP-7. Implant site integrity (no 
collapse) was observed in all BMP-7-stimulated implants. 
In 9 of 10 HA implants without BMP-7, partial implant col-
lapse was observed. All TCP implants without BMP-7 col-
lapsed (Fig. 5).
Fluorescent Labeling
The fluorescent labeling showed an enhanced effect of 
BMP-7 on bone formation starting at week 1 (xylenol or-
ange = orange yellow marker) in all the implants. At week 6, 
calcein green was observed in all specimens; nevertheless, 
only in BMP-7-loaded implants, homogeneous bone forma-
tion in the whole implant area was observed. In implants 
Fig. 4. in vivo 3D Ct scan of the head 1 week after placement of 5 craniotomies (exemplary scan, case 1, group 1). two anterior cra-
niotomies were grafted with Ha; 2 posterior craniotomies were grafted with BCp (the left side is grafted in the presence of Bmp-7). 
a control craniotomy nongrafted (left side lateral) remained unhealed at the end of the study, confirming the nature of the defect 
as a critical-size defect. the surface continuity of grafted area differs depending on the implant composition and in the presence 
of Bmp-7. Cranial defects loaded with Bmp-7 (left) are almost repaired. nevertheless, apparently unrepaired surface (irregularities) 
in the Bmp-7 group is composed of the newly mineralized bone, not assessable on Ct but evident on ESEm (Fig. 4). temporary vol-
ume changes on in vivo Ct are appreciated in Figure 3 (volume-rendered Ct image; iplan CmF 3; BrainlaB, Feldkirchen, Germany).
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not loaded with BMP-7, bone formation took place in an 
already collapsed implant site (Fig. 8). At week 8 (alizarin 
complexon = red marker), bone formation was observed 
again homogeneously in BMP-7 implants. By week 12 (dox-
ycycline = brown marker), a cortical-like bone was observed 
in the grafted site in the presence of BMP-7. In nonloaded 
implants, soft-tissue ingrowth in an irregular collapsed im-
plant site was observed (Fig. 8). The total fluorescent area 
measured at week 12 (brown marker) was similar in all 
specimens (Fig. 9), but in the non-BMP-7–loaded implants, 
the amount of bone on a delayed bone formation in weeks 
1, 6, and 8 was insufficient to repair the defect (Fig. 8).
Fig. 5. ESEm images of explanted grafted frontal bone (total core). Dotted lines denote site of implant 
and the corresponding extension of ideal skull surface in reference to the defect border: slight over-
growth of bone on top of nondegradable Ha in the presence of Bmp-7 is observed (above left). Ha 
without Bmp-7 is collapsed; the newly formed bone fails to preserve the skull contour (dotted line, above 
right). tCp in the presence of Bmp-7 is almost fully replaced by the newly formed bone. Due to fast deg-
radation, irregularities were observed on top of the grafted area (middle row left). tCp in the absence 
of Bmp-7 showed partial collapse (middle row right). BCp in the presence of Bmp-7 showed a homoge-
neous bone growth; no overgrowth was observed due to advanced ceramic degradation (below left). 
BCp in the absence of Bmp-7 is almost completely collapsed in reference to the skull profile (below right, 
undecalcified in mma-embedded specimen en block analyzed, composite images, scale bar: 3.5 mm).
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Fig. 6. area of the newly mineralized bone assessed by ESEm. Enhanced bone forma-
tion was observed as statistically significant in tCp ceramics in the presence of Bmp-7 
(P = 0.047); a slightly enhanced bone formation was observed in BCp in the presence 
of Bmp-7 (P = 0.059) but not with Ha. the relative bone overgrowth in Ha + Bmp-7 
ceramics observed in ESEm images corresponds to a bone growth shift due to the per-
sistent ceramic occupying the defect core (Fig. 4). nonimplanted ceramic (native ce-
ramic) confirm that measured gray values are correctly assessed as the newly formed 
bone and not as ceramic (normality test Shapiro-Wilk, failed P < 0.05).
Fig. 7. area of CpCs assessed by ESEm. Bmp-7 enhanced ceramic degradation on BCp 
and tCp. Ha remained unaltered in the presence of Bmp-7; a slight enhancement of 
the ceramic area is explained by bone formation in the microconnective system (nor-
mality test Shapiro-Wilk, failed P < 0.05).
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Fig. 8. Fluorochrome labeling of explanted grafted frontal bone (total core, xylenol orange/orange 
yellow marker at week 1; calcein green/green marker at week 6; alizarin complexon/red marker at 
week 8; doxycycline/brown marker at week 12). Dotted lines denote site of implant and the corre-
sponding extension of ideal skull surface in reference to the defect border: Ha is labeled starting at 
week 1 (orange yellow) in the presence of Bmp-7. Subsequent markers are observed in sequential lay-
ers. On the top, a cortical-like bone (brown) is observed (above left). Ha in the absence of Bmp-7 starts 
bone formation at week 6 (green) in an already collapsed implant (above right). tCp in the presence of 
Bmp-7 shows an intense fluorochrome uptake starting at week 1 (orange yellow); subsequent fluoro-
chromes are distributed homogeneously. a cortical-like bone (brown) is observed on the top (middle 
row left). tCp without Bmp-7 shows bone labeled at week 12 (brown). no grafted material is seen. the 
implant site is completely collapsed (middle row right). BCp in the presence of Bmp-7 shows homo-
geneous bone formation, starting at week 1 (orange yellow). the implant site shows bone maturity 
undistinguishable from the host bone (below left). BCp without Bmp-7 shows bone formation starting 
at week 6 (green); the implant site is already collapsed (below right, undecalcified in mma-embedded 
specimen en block analyzed, composite images, scale bar: 3.5 mm).
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Histology
The histology in the Giemsa staining showed no in-
flammatory reaction in the surrounding tissues including 
the frontal sinus. Bone formation was observed at the sur-
face of ceramic struts (macropores) and also inside the 
ceramic struts (micropores).
DISCUSSION
The beneficial effect of BMP-7 on bone formation, 
ceramic degradation, and creeping ceramic substitution 
could be proven in the presented experimental setting 
while the integrity of the implant surface remained un-
altered.
Effect of BMP-7 on CPCs as Cranial Implants—The 
Integrity of the Cranial Shape
Bone formation was seen in all implants whether load-
ed or not with BMP-7. Nevertheless, only in the presence 
of BMP-7, implant site integrity (no collapse of the grafted 
site) was observed. In BMP-7-loaded implants, a cortical-
like bone was observed in continuity to the skull profile. 
BMP-7 enhanced degradation of TCP and BCP ceramics 
by bone replacement resembling bone remodeling while the 
grafted site remained unchanged in shape. A slight bone 
overgrowth over skull profile was observed in HA/BMP-
7 ceramics due to limited degradability of HA. Docherty-
Skogh et al.21 reported about complete degradation of a 
hydrogel implant in the presence of 1.25 mg of BMP-2 for 
cranial reconstruction in a minipig after 3 months; nev-
ertheless, massive bone formation behind the skull pro-
file was observed. This issue underlines the importance to 
characterize each implant, considering the degradability 
in relation to the amount of BMP applied.
Ceramics nonloaded with BMP-7 collapsed, changing 
skull shape. Gosain et al.27 informed about unsuitability of 
CPC (HA, BCP) in the absence of BMP for augmentation 
of the facial skeleton (midface and frontal bone) because 
of unpredictable ceramic degradation, and thus unpre-
dictable shape of skull and facial skeleton.
To overcome unpredictable cranial implant shape, 
Engstrand et al.28 proposed a calcium phosphate cranial 
implant reinforced with a titanium mesh. Vital bone in-
side the mesh was observed 50 months after surgery in 
a follow-up study in 2 patients.29 The titanium scaffold 
embedment in the newly formed bone is not removable, 
making the calcium phosphate implant mechanically de-
pendent on the metallic construction. Since many years, 
titanium mesh has been used as a cast for bony reconstruc-
tion in the craniofacial area by using autologous bone 
graft or bone substitutes.2,30 Loss of titan implants because 
Fig. 9. Histomorphometry of fluorochromes detected at weeks 6 (green marker = 
calcein green), 8 (red marker = alizarin complexon), and 12 (brown marker = doxycy-
cline). no substantial differences are observed in terms of area of the newly formed 
bone in the presence or not of Bmp-7. nevertheless, when late bone formation oc-
curs as observed in implants not loaded with Bmp-7, bone formation takes place in 
an already collapsed scaffold (Fig. 7). this result underlines the critical role of Bmps at 
an early stage of bone healing. an enhanced bone formation was observed in Bmp-
7-loaded BCp at week 6 (early bone formation); bone formation decreased at week 8 
(P = 0.01). P values for intergroup comparisons are shown for 6, 8, and 12 weeks after 
implantation. One-way analysis of variance was used for intergroup comparisons at 6 
and 8 weeks and the Kruskal-Wallis test was used for comparison at 12 weeks.
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of infection remains a potential complication,30 beside 
the limitation of MRI studies because of metallic interfer-
ence.6 The full replacement of a bone implant should be 
the main goal in regenerative medicine.
Enhanced Degradation of Ceramics and Bone Remodeling
In the present study, BCP and TCP scaffolds loaded with 
BMP-7 showed a statistically enhanced degradation after 3 
months compared with scaffolds not loaded with BMP-7. 
This time span seems to be appropriate when considering a 
growing infant. Clinically, 2–3 months after craniosynostosis 
surgery (release of premature ossified cranial suture by bone 
flap at age 8 months), unrestricted skull expansion is mea-
surable by 3D photography, despite osteosynthesis fixation 
with resorbable materials (personal observation). In an in-
fant minipig craniectomy model, enhanced bone formation 
induced by BMP-7 in a collagen carrier showed unrestricted 
skull expansion as well.13 The present ceramic combined 
with BMP-7 seems to be suitable for the treatment of cranial 
defects in the growing infant and consequently in adults.
Temporal Bone Formation Assessed by Fluorescent Labeling
In vivo data from the fluorescent labeling disclosed the 
pattern of bone formation. Early bone formation at week 
1 (seventh day) was observed in the presence of BMP-7 
in all ceramics; consequently, further appositional bone 
formation was undisturbed. Sato and Urist31 described 
BMP-induced bone formation as an “irreversible pro-
cess.” Ceramics not loaded with BMP-7 showed the first 
fluorochrome (calcein green) at week 6; by that time, 
scaffolds were almost collapsed, an irreversible event for 
further undisturbed bone formation. Shen et al.32 recently 
informed about bone formation in the mouse calvarian 
model by using a functionalized silk fibroin nanohydroxy-
apatite ceramic loaded with stromal cell–derived factor-1 
and BMP-2. After initial rapid release of stromal cell–de-
rived factor-1 in the first days, BMP-2 was released over a 
period of 3 weeks, showing enhanced bone formation at 
week 12.32 Despite enhanced bone formation, the biofunc-
tionalized cranial implant site showed an irregular and 
depressed skull surface in profile. Sustained release of bio-
active factors for bone formation should be matched with 
the degradability and resorptive properties of the bone 
substitute to be used. Sustained bone formation could be 
appropriate for less resorbable and degradable materi-
als as HA; nevertheless, fast degradable materials such as 
TCP or supplemental materials such as silk fibroin need a 
stronger and earlier stimulus for bone formation, as BMP 
does, before the bone substitute material disappears.
Ceramic Design and Composition
BCP ceramic in a ratio of 60%/40% seems to be appro-
priate in terms of degradability under the selected con-
ditions. The synchronized degradability with enhanced 
bone formation induced by BMP-7 supports ceramic 
creeping substitution, avoiding collapse at the implant 
site. Schumacher et al.33 evaluated bone marrow stromal cells 
on BCP 60%/40% produced by rapid prototyping tech-
nique in a static and dynamic culture. Cell differentiation 
was observed in both culture conditions, but cell growth 
and migration was enhanced in a dynamic culture.33 The 
suitability of CPC to be designed via rapid prototyping 
technique, considering the inclusion of a wide range of 
interconnecting pore system,14 makes this material prom-
ising for tailoring as a patient-specific implant, with match-
ing effect on cellular responses and implant shape.
Because the integrity of the implant site after creeping 
substitution of the ceramic is of paramount importance 
in cranial reconstruction, mechanism of degradation (dis-
solution) and/or cellular digestion (osteoclast) should be 
clarified in the future. In preliminary studies on the pres-
ent ceramic, chemical dissolution and cellular resorption 
of CPC could be proven in vitro.34,35 Further in vivo studies 
are necessary to improve our understanding of the role of 
osteoclasts in ceramic digestion.
Implant Proximity to the Frontal Sinus
In the present study, the sinus mucosa was prepared 
and dissected from the sinus septa. In the Giemsa histol-
ogy, noninflammatory infiltration was observed. The CT 
showed in vivo no sign of sinus involvement during the ex-
perimental period. Similar results are available for maxil-
lary sinus elevation with different bone substitutes.24,36 The 
involvement of the frontal sinus has been reported as a criti-
cal issue for PMMA cranial implants, an infection being the 
major cause for implant loss.37,38 The degradability of CPC 
scaffolds makes them suitable for forehead reconstruction.
CONCLUSIONS
BMP-7 enhances bone formation and ceramic degra-
dation while the grafted site remains unaltered in its in-
tegrity. Early bone formation induced by BMP supports 
further bone apposition throughout the scaffold. Late 
bone formation in nonloaded scaffolds takes place in an 
already collapsed grafted site. Ceramics should be char-
acterized in terms of degradability to match the amount 
of BMP needed for bone enhancement, resembling an 
equilibrated bone remodeling system.
J. Camilo Roldán, MD, DMD, PhD
Department of Cranio-Maxillofacial Plastic Surgery
University of Regensburg
Franz-Josef-Strauß-Allee 11
93053 Regensburg, Germany
E-mail: jcamilo.roldan@yahoo.com
ACKNOWLEDGMENTS
Authors greatly thank Prof. Slobodan Vukicevic, Laboratory 
for Mineralized Tissues Center for Translational and Clinical Re-
search, University of Zagreb School of Medicine, for providing us 
with BMP-7 and his critical evaluation of the study design and 
Antje Boettinger for her technical support at the Bone Research 
Lab at the Department of Cranio-Maxillofacial Plastic Surgery.
REFERENCES
 1. Hollister SJ. Porous scaffold design for tissue engineering. Nat 
Mater. 2005;4:518–524.
 2. Warnke PH, Springer IN, Wiltfang J, et al. Growth and trans-
plantation of a custom vascularised bone graft in a man. Lancet. 
2004;364:766–770.
 11
Roldán et al. • BMP-7 Preserves Surface Integrity of Cranioplasty
 3. Goodrich JT, Sandler AL, Tepper O. A review of reconstructive 
materials for use in craniofacial surgery bone fixation materials, 
bone substitutes, and distractors. Childs Nerv Syst. 2012;28:1577–
1588.
 4. Hench LL, Polak JM. Third-generation biomedical materials. 
Science. 2002;295:1014–1017.
 5. Rammos CK, Cayci C, Castro-Garcia JA, et al. Patient-specific 
polyetheretherketone implants for repair of craniofacial defects. 
J Craniofac Surg. 2015;26:631–633.
 6. Cunningham AS, Harding S, Chatfield DA, et al. Metallic neuro-
surgical implants for cranial reconstruction and fixation: assess-
ment of magnetic field interactions, heating and artefacts at 3.0 
Tesla. Br J Neurosurg. 2005;19:167–172.
 7. Gosain AK; Plastic Surgery Eductional Foundation DATA 
Committee. Biomaterials for reconstruction of the cranial vault. 
Plast Reconstr Surg. 2005;116:663–666.
 8. Gosain AK, Riordan PA, Song L, et al. A 1-year study of osteo-
induction in hydroxyapatite-derived biomaterials in an adult 
sheep model: part II. Bioengineering implants to optimize bone 
replacement in reconstruction of cranial defects. Plast Reconstr 
Surg. 2004;114:1155–63; discussion 1164.
 9. Greene AK, Mulliken JB, Proctor MR, et al. Primary grafting 
with autologous cranial particulate bone prevents osseous de-
fects following fronto-orbital advancement. Plast Reconstr Surg. 
2007;120:1603–1611.
 10. Tessier P, Kawamoto H, Matthews D, et al. Autogenous bone 
grafts and bone substitutes–tools and techniques: I. A 20,000-
case experience in maxillofacial and craniofacial surgery. Plast 
Reconstr Surg. 2005;116:6S–24S.
 11. Tessier P, Kawamoto H, Posnick J, et al. Taking calvarial grafts–
tools and techniques: VI. The splitting of a parietal bone “flap”. 
Plast Reconstr Surg. 2005;116(5 suppl):74S–88S; discussion 92S.
 12. Roldán JC, Jepsen S, Miller J, et al. Bone formation in the pres-
ence of platelet-rich plasma vs. bone morphogenetic protein-7. 
Bone. 2004;34:80–90.
 13. Springer IN, Açil Y, Kuchenbecker S, et al. Bone graft versus 
BMP-7 in a critical size defect–cranioplasty in a growing infant 
model. Bone. 2005;37:563–569.
 14. Roldán JC, Chang E, Kelantan M, et al. Quantifying migration 
and polarization of murine mesenchymal stem cells on differ-
ent bone substitutes by confocal laser scanning microscopy. 
J Craniomaxillofac Surg. 2010;38:580–588.
 15. Detsch R, Uhl F, Deisinger U, et al. In vitro studies of cell 
growth on three differently fabricated hydroxyapatite ceramic 
scaffolds for bone tissue engineering. Key Eng Mater. 2008;361–
363:1181–1184.
 16. Roldán JC, Detsch R, Schaefer S, et al. Bone formation and 
degradation of a highly porous biphasic calcium phosphate 
ceramic in presence of BMP-7, VEGF and mesenchymal stem 
cells in an ectopic mouse model. J Craniomaxillofac Surg. 
2010;38:423–430.
 17. Urist MR, Lietze A, Dawson E. [beta]-tricalcium phosphate deliv-
ery system for bone morphogenetic protein. Clin Orthop Relat Res. 
1984;187:277.
 18. Ripamonti U, Ramoshebi LN, Matsaba T, et al. Bone induction 
by BMPs/OPs and related family members in primates. J Bone 
Joint Surg Am. 2001;83-A(suppl 1, pt 2):S116–S127.
 19. Deisinger U. Synthetisches Knochenersatzmaterial mit spongiosa-ähnli-
cher Struktur. Berlin: Mensch & Buch Verlag; 2009.
 20. Ripamonti U. Bone induction by recombinant human osteogen-
ic protein-1 (hOP-1, BMP-7) in the primate Papio ursinus with 
expression of mRNA of gene products of the TGF-beta super-
family. J Cell Mol Med. 2005;9:911–928.
 21. Docherty-Skogh AC, Bergman K, Waern MJ, et al. Bone mor-
phogenetic protein-2 delivered by hyaluronan-based hydrogel 
induces massive bone formation and healing of cranial defects 
in minipigs. Plast Reconstr Surg. 2010;125:1383–1392.
 22. Parfitt AM. Bone histomorphometry: standardization of nomen-
clature, symbols and units (summary of proposed system). Bone. 
1988;9:67–69.
 23. Rahn BA. Fluorochrome labelling of bone dynamics. Eur Cells 
and Mater. 2003;5:41.
 24. Roldán JC, Knueppel H, Schmidt C, et al. Single-stage sinus aug-
mentation with cancellous iliac bone and anorganic bovine bone 
in the presence of platelet-rich plasma in the miniature pig. Clin 
Oral Implants Res. 2008;19:373–378.
 25. Donath K, Breuner G. A method for the study of undecal-
cified bones and teeth with attached soft tissues. The Säge-
Schliff (sawing and grinding) technique. J Oral Pathol. 
1982;11:318–326.
 26. Plenk H Jr, Shum JC, Cruise GM, et al. Cartilage and bone neo-
formation in rabbit carotid bifurcation aneurysms after endovas-
cular coil embolization. Eur Cell Mater. 2008;16:69–79.
 27. Gosain AK, Riordan PA, Song L, et al. A 1-year study of hy-
droxyapatite-derived biomaterials in an adult sheep model: III. 
Comparison with autogenous bone graft for facial augmenta-
tion. Plast Reconstr Surg. 2005;116:1044–1052.
 28. Engstrand T, Kihlström L, Neovius E, et al. Development of a bio-
active implant for repair and potential healing of cranial defects. 
J Neurosurg. 2014;120:273–277.
 29. Engstrand T, Kihlström L, Lundgren K, et al. Bioceramic implant 
induces bone healing of cranial defects. Plast Reconstr Surg Glob 
Open. 2015;3:e491.
 30. Kuttenberger JJ, Hardt N. Long-term results following recon-
struction of craniofacial defects with titanium micro-mesh sys-
tems. J Craniomaxillofac Surg. 2001;29:75–81.
 31. Sato K, Urist MR. Induced regeneration of calvaria by bone 
morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res. 
1985;197:301–311.
 32. Shen X, Zhang Y, Gu Y, et al. Sequential and sustained release 
of SDF-1 and BMP-2 from silk fibroin-nanohydroxyapatite scaf-
fold for the enhancement of bone regeneration. Biomaterials. 
2016;106:205–216.
 33. Schumacher M, Uhl F, Detsch R, et al. Static and dynamic cultiva-
tion of bone marrow stromal cells on biphasic calcium phosphate 
scaffolds derived from an indirect rapid prototyping technique. 
J Mater Sci Mater Med. 2010;21:3039–3048.
 34. Schaefer S, Detsch R, Uhl F, et al. How degradation of calcium 
phosphate bone substitute materials is influenced by phase com-
position and porosity. Adv Eng Mater. 2011;13:342–350.
 35. Detsch R, Boccaccini AR. The role of osteoclasts in bone tissue 
engineering. J Tissue Eng Regen Med. 2015;9:1133–1149.
 36. Klongnoi B, Rupprecht S, Kessler P, et al. Influence of plate-
let-rich plasma on a bioglass and autogenous bone in sinus 
augmentation. An explorative study. Clin Oral Implants Res. 
2006;17:312–320.
 37. Marchac D, Greensmith A. Long-term experience with methyl-
methacrylate cranioplasty in craniofacial surgery. J Plast Reconstr 
Aesthet Surg. 2008;61:744–752; discussion 753.
 38. Bello-Rojas G, Whitney M, et al. Long-term results of craniofacial 
implantation: a return to methyl methacrylate. Eur J Plast Surg. 
2012;35:177–180.
